Cargando…
Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents
BACKGROUND: In vivo animal models of familial amyotrophic lateral sclerosis (fALS) are widely used to delineate the potential role that genetic mutations play in the neurodegenerative process. While these models are extensively used for establishing the safety and efficacy of putative therapeutics d...
Autores principales: | Zwiegers, Pierre, Lee, Grace, Shaw, Christopher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134475/ https://www.ncbi.nlm.nih.gov/pubmed/25103619 http://dx.doi.org/10.1186/1477-5751-13-14 |
Ejemplares similares
-
Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1(G93A) Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
por: Pehar, Mariana, et al.
Publicado: (2014) -
Extreme diversity of 12 cations in folding ALS-linked hSOD1 unveils novel hSOD1-dependent mechanisms for Fe(2+)/Cu(2+)-induced cytotoxicity
por: Lim, Liangzhong, et al.
Publicado: (2023) -
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS
por: De Rose, Francescaelena, et al.
Publicado: (2017) -
Effects of RAGE inhibition on the progression of the disease in hSOD1(G93A) ALS mice
por: Liu, Liping, et al.
Publicado: (2020) -
Microglia Morphological Changes in the Motor Cortex of hSOD1(G93A) Transgenic ALS Mice
por: Migliarini, Sara, et al.
Publicado: (2021)